Stay updated on Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.

Latest updates to the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, representing a minor metadata update to the study record. It does not indicate changes to the study data or displayed content beyond the revision label.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedClinicalTrials.gov’s page footer revision label was updated from v3.5.2 to v3.5.3, reflecting an interface/system release rather than a change to the study record.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No other content changes are reflected in additions or deletions.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated to v3.5.0. The previous version v3.4.3 was removed.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check110 days agoChange DetectedRevision: v3.4.2 was added; the notice about government funding interruptions and the prior Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.